New Coronavirus Infection and Diabetes Mellitus
Keywords:
Coronavirus, chronic diseases, diabetes mellitus, viral attack
Abstract
In this paper, a new approach and analysis of the new coronavirus infection and diabetes mellitus is given. Moreover, the authors determined the clinical course and life quality of patients with 2 type diabetes mellitus who have had a coronavirus infection.
References
1. М.В. Шестакова*, Н.Г. Мокрышева, И.И. Дедов https://cyberleninka.ru/article/n/saharnyy-diabet-v-usloviyah-virusnoy-pandemii-covid-19-osobennosti-techeniya-i-lecheniya.
2. International Diabetes Federation. IDF Diabetes Atlas, 9th dn. Brussels, Belgium; 2019, doi: https://doi.org/10.1001/jama.2020.4683.
3. Epidemiology Working Group for Ncip Epidemic Response. Avalable from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
4. Глыбочко П.В., Фомин В.В., Авдеев С.В., и др. Клиническая характеристика 1007 больных тяжелой SARS-COV-2 пневмонией, нуждавшихся в респираторной поддержке // Клиническая фармакология и терапия.2020.Т.29.№2.С.21−29. 18.
5. Андреева А.В., Маркова Т.Н., Анциферов М.Б. Особенности ведения пациентов с сахарным диабетом и COVID-19 // Доктор.Ру. 2021; 20(2): 11– 20. DOI: 10.31550/1727-2378-2021-20-2-11-20
6. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China // Lancet.2020.395.(10223).497–506. DOI:10.1016/S0140-6736(20)30183-5
7. Sardu C., D'Onofrio N., Balestrieri M.L. et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? // Diabetes Care. 2020.43.(7). 1408– 1415.DOI:10.2337/dc20-0723
8. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, https://doi.org/10.1016/j.dsx.2020.04.018.
9. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol.
10. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18 (4):844-7. doi:10.1111/jth.14768.
11. Pretorius L, Thomson GJA, Adams RCM, et al. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol. 2018; 17:141. Doi: 10.1186/s12933-018-0783-z.
12. Pretorius L, Thomson GJA, Adams RCM, et al. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol. 2018; 17: 141. doi: 10.1186/s12933-018-0783-z
13. Online map of the spread of coronavirus. (In Russ.) Онлайн карта распространения коронавируса. [Электронный ресурс]. URL: https://coronavirus-monitor.ru/.
14. Bode B, Garrett V, Messler J, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020; 14(4):813-21. Doi: 10.1177/1932296820924469.
15. Roca-Ho H, Riera M, Palau V, et al. Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse. Int J Mol Sci. 2017; 18(3):563. Doi: 10.3390/ijms18030563.
16. Rao S, Lau A, So HC. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care. 2020;43(7):1416-26. doi:10.2337/dc20-0643.
17. Глыбочко П.В., Фомин В.В., Моисеев С.В., и др. Исходы у больных с тяжелым течением COVID-19, госпитализированных для респираторной поддержки в отделения реанимации и интенсивной терапии //Клиническая фармакология и терапия.2020.Т.29.№.3.С.25-36.
2. International Diabetes Federation. IDF Diabetes Atlas, 9th dn. Brussels, Belgium; 2019, doi: https://doi.org/10.1001/jama.2020.4683.
3. Epidemiology Working Group for Ncip Epidemic Response. Avalable from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
4. Глыбочко П.В., Фомин В.В., Авдеев С.В., и др. Клиническая характеристика 1007 больных тяжелой SARS-COV-2 пневмонией, нуждавшихся в респираторной поддержке // Клиническая фармакология и терапия.2020.Т.29.№2.С.21−29. 18.
5. Андреева А.В., Маркова Т.Н., Анциферов М.Б. Особенности ведения пациентов с сахарным диабетом и COVID-19 // Доктор.Ру. 2021; 20(2): 11– 20. DOI: 10.31550/1727-2378-2021-20-2-11-20
6. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China // Lancet.2020.395.(10223).497–506. DOI:10.1016/S0140-6736(20)30183-5
7. Sardu C., D'Onofrio N., Balestrieri M.L. et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? // Diabetes Care. 2020.43.(7). 1408– 1415.DOI:10.2337/dc20-0723
8. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, https://doi.org/10.1016/j.dsx.2020.04.018.
9. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol.
10. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18 (4):844-7. doi:10.1111/jth.14768.
11. Pretorius L, Thomson GJA, Adams RCM, et al. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol. 2018; 17:141. Doi: 10.1186/s12933-018-0783-z.
12. Pretorius L, Thomson GJA, Adams RCM, et al. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol. 2018; 17: 141. doi: 10.1186/s12933-018-0783-z
13. Online map of the spread of coronavirus. (In Russ.) Онлайн карта распространения коронавируса. [Электронный ресурс]. URL: https://coronavirus-monitor.ru/.
14. Bode B, Garrett V, Messler J, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020; 14(4):813-21. Doi: 10.1177/1932296820924469.
15. Roca-Ho H, Riera M, Palau V, et al. Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse. Int J Mol Sci. 2017; 18(3):563. Doi: 10.3390/ijms18030563.
16. Rao S, Lau A, So HC. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care. 2020;43(7):1416-26. doi:10.2337/dc20-0643.
17. Глыбочко П.В., Фомин В.В., Моисеев С.В., и др. Исходы у больных с тяжелым течением COVID-19, госпитализированных для респираторной поддержки в отделения реанимации и интенсивной терапии //Клиническая фармакология и терапия.2020.Т.29.№.3.С.25-36.
Published
2022-11-25
How to Cite
D. K, N., D. A, U., N. G, S., & Sh. N., I. (2022). New Coronavirus Infection and Diabetes Mellitus. Central Asian Journal of Medical and Natural Science, 3(6), 172-177. https://doi.org/10.17605/cajmns.v3i6.1189
Section
Articles
